Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®
1. Valneva showcases IXCHIQ® at the 25th World Vaccine Congress. 2. Company participates in several key presentations on vaccine innovations. 3. Valneva is a finalist for Best Biotech and Prophylactic Vaccine awards. 4. IXCHIQ® is the first licensed chikungunya vaccine globally. 5. Chikungunya virus poses a growing public health challenge.